Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FY220
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $110,744
Award facts
- Contract value 100% obligated
- $110,744.36 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $110,744.36 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under Amerisourcebergen's parent organization, Cencora, Inc. The work will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under the broader context of federal pharmaceutical supply chain management, wherein Amerisourcebergen serves as a critical vendor for military and federal healthcare systems.
This delivery order falls under the Pharmaceutical Prime Vendor Global Program framework administered by DLA Troop Support Medical, which leverages Amerisourcebergen's significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., maintains an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, positioning the organization as a primary source for comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. These contracts enable delivery of brand-name and generic medications, specialty pharmaceuticals, vaccines, and related medical commodities across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DU26FY220?
SPE2DU26FY220 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DU26FY220 worth?
The government has obligated $110,744 on SPE2DU26FY220.
Is contract SPE2DU26FY220 an order under another contract?
Yes. SPE2DU26FY220 is a delivery order under SPE2DU25D4115, an indefinite delivery contract.
Was contract SPE2DU26FY220 competed?
The extent of competition for SPE2DU26FY220 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award